Northern Institute for Cancer Research

Staff Profile

Dr Sarah Fordham

Research Associate


Areas of expertise

Acute myeloid leukaemia - development of novel therapeutics, cytogenetics, disease evolution


2011 - PhD (Cancer Research), Newcastle University

2007 - Postgraduate Certificate of Competency in Clinical Cytogenetics

2005 - BSc (1st Class with Honours) Human Genetics, Newcastle University

Previous Positions

2007 - 2011   PhD student, Molecular Carcinogenesis group, Northern Institute for Cancer Research, Newcastle University

2005 - 2007   Clinical Cytogeneticist (Grade A), Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Trust


My research is focussed on chemotherapy of acute myeloid leukaemia (AML). In particular I am interested in whether DNA repair pathway defects, commonly observed in AML patients, can be exploited to both improve current therapies and facilitate development of novel agents. I also have a keen interest in determining the contribution of conventional chemotherapeutics to the development of relapsed disease via generation of DNA mutations.


Student supervision

Devi Suchitra-Devi (PhD)       2017 - date

Nurettin Ayvali (PhD)              2016 - date

Emmanouela Soura (MPhil)   2016 - 2018

Mohd Fadly (PhD)                  2014 - date